Tokyo, Jan. 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060323) titled 'A multicenter retrospective study on real-world clinical practice and treatment outcomes of urologic sarcomas' on Jan. 25.
Study Type:
Observational
Primary Sponsor:
Institute - Akita University School of Medicine
Condition:
Condition - Patients who received treatment for retroperitoneal sarcoma or spermatic cord/scrotal sarcoma at the participating institutions
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - The aim of this study was to clarify real-world clinical practice patterns and treatment outcomes of urologic sarcomas in Japan and to identify their clinical characteristics.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Patients aged 18 and 100 years with a histopathological diagnosis of sarcoma.
The study included patients who initiated treatment between January 2004 and March 2025.
Key exclusion criteria - Patients who declined to participate
Target Size - 350
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 06 Month 16 Day
Anticipated trial start date - 2025 Year 06 Month 16 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069003
Disclaimer: Curated by HT Syndication.
